Preventive effect of imperatorin against doxorubicin-induced cardiotoxicity through suppression of NLRP3 inflammasome activation
Journal of Natural Medicines · 2025
DOI: 10.1007/s11418-024-01850-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Medicines, 2025. Verfasst von Hao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, China. Hauptthemen laut MEDLINE: Doxorubicin, NLR Family, Pyrin Domain-Containing 3 Protein, Cardiotoxicity, Inflammasomes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Project Founded by the Education Department of Jiangxi Province, Open Project of Jiangxi Provincial Key Laboratory of Drug Design and Evaluation.
Abstract (Originalsprache)
Cardiotoxicity is one of the major obstacles to anthracycline chemotherapy. Anthracycline cardiotoxicity is closely associated with inflammation. Imperatorin (IMP), a furocoumarin ingredient extracted from Angelica dahurica, might have potential activity in preventing anthracycline cardiotoxicity due to its anti-cancer, anti-inflammatory, anti-oxidant, cardioprotective properties. This study aims to reveal the effect of IMP on doxorubicin (DOX)-induced cardiotoxicity and its underlying mechanism. We established a rat model of DOX-induced cardiotoxicity by intraperitoneal injection with DOX (1.25 mg/kg twice weekly for 6 weeks), and found that both IMP (25 mg/kg and 12.5 mg/kg) and dexrazoxane 12.5 mg/kg relieved DOX-induced reductions in heart weight, change in cardiac histopathology, and elevated serum levels of LDH, AST and CK-MB. Moreover, DOX upregulated mRNA levels of NLRP3, CASP1, GSDMD, ASC, IL-1β and IL-18, elevated protein expressions of NLRP3, ASC, GSDMD-FL, GSDMD-N, pro‑caspase‑1, caspase‑1 p20, pro‑IL‑1β and IL‑1β in heart tissues, as well as increased serum levels of pro-inflammatory cytokines including IL-1β and IL-18, however both of IMP and dexrazoxane suppressed these alterations. In addition, we carried out neonatal rat cardiomyocytes experiments to confirm the results of the in vivo study. Consistently, pretreatment with IMP 25 µg/mL relieved DOX (1 μg/mL)-induced cardiomyocytes injury, including decreased cell viability and reduced supernatant LDH. IMP inhibited DOX-induced activation of NLRP3 inflammasome in cardiomyocytes. In conclusion, IMP had a protective effect against DOX-induced cardiotoxicity via repressing the activation of NLRP3 inflammasome. These findings suggest that IMP may be a promising alternative or adjunctive drug for the prevention of anthracycline cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, China.
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, Nanchang, 330013, China.
- School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, China. tangxilan1983@163.com.
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, Nanchang, 330013, China. tangxilan1983@163.com.
Förderung
- National Natural Science Foundation of China
- Science and Technology Project Founded by the Education Department of Jiangxi Province
- Open Project of Jiangxi Provincial Key Laboratory of Drug Design and Evaluation
- Open Project of Engineering Center of Jiangxi University for Fine Chemicals
- Jiangxi Science & Technology Normal University Graduate Innovation Special Funds Project
Zitieren
APA
Zhang, H., Ding, X., Qiu, Y., Xie, M., Wang, H., Li, T., Bao, H., Huang, S., Xiong, Y., & Tang, X. (2025). Preventive effect of imperatorin against doxorubicin-induced cardiotoxicity through suppression of NLRP3 inflammasome activation. Journal of Natural Medicines. https://doi.org/10.1007/s11418-024-01850-x
Vancouver
Zhang H, Ding X, Qiu Y, Xie M, Wang H, Li T, et al. Preventive effect of imperatorin against doxorubicin-induced cardiotoxicity through suppression of NLRP3 inflammasome activation. Journal of Natural Medicines. 2025. doi:10.1007/s11418-024-01850-x
BibTeX
@article{Zhang2025,
author = {Zhang, Hao and Ding, Xiaoyun and Qiu, Yumei and Xie, Mengdie and Wang, Hu and Li, Tingting and Bao, Huiyun and Huang, Si and Xiong, Yinhua and Tang, Xilan},
title = {Preventive effect of imperatorin against doxorubicin-induced cardiotoxicity through suppression of NLRP3 inflammasome activation},
journal = {Journal of Natural Medicines},
year = {2025},
doi = {10.1007/s11418-024-01850-x}
}
EUVIMED